149 related articles for article (PubMed ID: 6109013)
21. Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.
Reches A; Burke RE; Kuhn CM; Hassan MN; Jackson VR; Fahn S
J Pharmacol Exp Ther; 1983 Jun; 225(3):515-21. PubMed ID: 6864517
[TBL] [Abstract][Full Text] [Related]
22. Serotonergic involvement in haloperidol-induced catalepsy.
Neal-Beliveau BS; Joyce JN; Lucki I
J Pharmacol Exp Ther; 1993 Apr; 265(1):207-17. PubMed ID: 8386235
[TBL] [Abstract][Full Text] [Related]
23. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
[TBL] [Abstract][Full Text] [Related]
24. On some central effects of elymoclavine.
Roussinov K; Georgiev V; Petkov V; Lazarova M; Petkova B; Shopova S; Markovska V; Getova D; Draganova S
Acta Physiol Pharmacol Bulg; 1984; 10(4):28-35. PubMed ID: 6442955
[TBL] [Abstract][Full Text] [Related]
25. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors.
Sanberg PR
Nature; 1980 Apr; 284(5755):472-3. PubMed ID: 7189016
[TBL] [Abstract][Full Text] [Related]
26. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
Skrinskaia IuA; Popova NK; Nikulina EM; Kulikov AV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1032-9. PubMed ID: 9472169
[TBL] [Abstract][Full Text] [Related]
27. Modification of dopaminergic transmission by thyrotropin-releasing hormone.
Narumi S; Nagawa Y
Adv Biochem Psychopharmacol; 1983; 36():185-97. PubMed ID: 6305147
[TBL] [Abstract][Full Text] [Related]
28. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
29. Effects of dopamine, apomorphine gamma-hydroxybutyric acid, haloperidol and pimozide on reflex bradycardia in rats.
Chen FF; Lin MT
J Pharmacol Exp Ther; 1980 Aug; 214(2):427-32. PubMed ID: 7391987
[TBL] [Abstract][Full Text] [Related]
30. Postsynaptic striatal dopamine agonist or antagonist actions of (+) or (-) 3-PPP and modification after receptor deafferentation.
Oberlander C; Boissier JR
J Pharmacol; 1983; 14(4):401-4. PubMed ID: 6423905
[TBL] [Abstract][Full Text] [Related]
31. Dose-dependent response of central dopaminergic systems to buspirone in mice.
Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Gursale SC; Balsara JJ
Indian J Exp Biol; 2008 Oct; 46(10):704-14. PubMed ID: 19024168
[TBL] [Abstract][Full Text] [Related]
32. CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.
Rugsley TA; Davis MD; Akunne HC; Cooke LW; Whetzel SZ; MacKenzie RG; Shih YH; van Leeuwen DH; DeMattos SB; Georgic LM
J Pharmacol Exp Ther; 1995 Aug; 274(2):898-911. PubMed ID: 7636753
[TBL] [Abstract][Full Text] [Related]
33. The effect of blockade of dopamine receptors on the inhibition of episodic luteinizing hormone release during electrical stimulation of the arcuate nucleus in ovariectomized rats.
Gallo RV
Endocrinology; 1978 Apr; 102(4):1026-35. PubMed ID: 744005
[TBL] [Abstract][Full Text] [Related]
34. Lack of a strong influence of neuroleptic decanoates on dopaminergic and GABAergic functions.
Ossowska K; Wolfarth S
Pol J Pharmacol; 1995; 47(2):99-107. PubMed ID: 8688897
[TBL] [Abstract][Full Text] [Related]
35. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
Zharkovskiĭ AM; Nurk AM
Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
[TBL] [Abstract][Full Text] [Related]
36. A role for dopamine in growth hormone regulation in the dog.
Casanueva F; Betti R; Cocchi D; Zanardi P; Motta T; Müller EE
Endocrinology; 1981 Apr; 108(4):1469-75. PubMed ID: 7472276
[TBL] [Abstract][Full Text] [Related]
37. Enhanced sensitivity to pentobarbital in haloperidol or pimozide treated mice and rats.
Bhargava HN
Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):267-84. PubMed ID: 7394324
[TBL] [Abstract][Full Text] [Related]
38. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
[TBL] [Abstract][Full Text] [Related]
39. Studies on the mechanism of postetorphine catalepsy. Effects of clotiapine, haloperidol and rompun on postetorphine changes in concentrations of dopamine and noradrenaline in central nervous system of rats.
Kania BF
Acta Physiol Pol; 1980; 31(1):9-16. PubMed ID: 6103632
[TBL] [Abstract][Full Text] [Related]
40. Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain.
Karolewicz B; Antkiewicz-Michaluk L; Michaluk J; Vetulani J
Eur J Pharmacol; 1996 Oct; 313(3):181-6. PubMed ID: 8911913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
